Clearance Summary
everlinQ endoAVF System received FDA 510(k) clearance under submission number DEN160006, sponsored by Tva Medical, Inc.. The device was reviewed via the Direct premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 2018-06-22.
- Submission: DEN160006
- Applicant / Sponsor: Tva Medical, Inc.
- Clearance pathway: Direct
- Review panel: Cardiovascular
- Device class: Class II
- Regulation citation: 21 CFR 870.1252
- Decision date: 2018-06-22
Classification & Regulation
This clearance is catalogued under FDA product code PQK and 21 CFR 870.1252, within the Cardiovascular review panel as a Class II device.